Table 4.
IL15, sIL2-R and sTNF-R1 levels in active (1), inactive (2) patients and control group (3)
| Active | Inactive | Control | P | P (95% CI) | P | |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 1 versus 2 | 1 versus 3 | 2 versus 3 | |
| IL-15 | 47.6 ± 170 | 25.15 ± 240 | 28.5 ± 28.89 | NS | 0.016 (1.39–57.1) | NS |
| sIL-2R | 314 ± 388 | 235.3 ± 269 | 144.3 ± 152.9 | NS | 0.05 (0.4–331) | NS |
| sTNF-R1 | 350 ± 388 | 294.7 ± 204.7 | 205.9 ± 205.9 | NS | 0.031 (15.1–321.5) | NS |
P statistic and 95%CI between active patients and inactive patients; active patients and controls, inactive patients and controls